Fig. 2: p32 silencing decreases the expression level of oncogenes and EMT markers both in mouse and human melanoma cells in vitro.

A Immunoblots showing the expression level of oncogenes and EMT markers and B, C relative mRNA level of various oncogenes and EMT markers in ctrl shRNA and p32 shRNA-treated B16F10 and A375 cells, respectively. All the data are represented as mean ± SD. Student’s t-test was used for all statistical analyses, n = 3 (***P ≤ 0.001, **P ≤ 0.01, *P ≤ 0.05).